|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.415 USD | -9.26% |
|
+3.74% | +190.00% |
| Dec. 09 | Immix Biopharma announces closing of upsized $100 million underwritten offering of common stock and pre-funded warrants | RE |
| Dec. 08 | Immix Biopharma Prices $100 Million Offering | MT |
Chart calendar Immix Biopharma, Inc.
Upcoming events on Immix Biopharma, Inc.
No events available
Past events on Immix Biopharma, Inc.
| 2025-12-07 | Investor Meeting - Key Opinion Leader |
| 2025-12-07 | American Society of Hematology Meeting - Abstract Number: 25-14730 |
| 2025-12-01 | Piper Sandler Healthcare Conference |
| 2025-11-13 | Stifel Healthcare Conference |
| 2025-11-11 | Guggenheim Healthcare Innovation Conference |
| 2025-06-20 | Annual General Meeting |
| 2025-06-03 | Investor Meeting - Key Opinion Leader |
| 2025-06-03 | American Society of Clinical Oncology Meeting - Abstract Number: 7508 |
| 2024-12-19 | Business Update Call |
| 2024-12-10 | American Society of Hematology Meeting |
| 2024-12-09 | American Society of Hematology Meeting - Publication No:894 |
| 2024-06-11 | Annual General Meeting |
| 2024-05-10 | American Society of Gene & Cell Therapy Meeting - HBI0101 |
| 2023-12-11 | American Society of Hematology Meeting - Publication Number #4852 |
| 2023-12-10 | American Society of Hematology Meeting - Publication No - #538 |
| 2023-12-05 | JMP Securities Hematology And Oncology Summit |
| 2023-11-29 | Investor Meeting - Key Opinion Leaders |
| 2023-10-25 | Trailblazers Private Company Healthcare Conference |
| 2023-09-28 | International Myeloma Society Meeting |
| 2023-09-27 | International Myeloma Society Meeting |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 1,00 - | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -8,22 -6,21 -32.42% | -16,1 -14,4 -12.38% | 0,00 0,00 - | -25,8 | -24,3 |
|
EBIT Million USD | Released Forecast Spread | -8,22 -6,65 -23.66% | -16,1 -14,9 -8.64% | -22,7 -25,3 10.44% | -26,4 | -30,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,22 -6,87 -19.67% | -15,6 -14,5 -7.48% | -21,7 -24,2 10.64% | -25,5 | -30,4 |
|
Net income Million USD | Released Forecast Spread | -8,23 -6,87 -19.74% | -15,4 -14,5 -6.32% | -21,6 -24,3 10.94% | -25,5 | -30,5 |
|
EPS USD | Released Forecast Spread | -0,59 -0,50 -18.79% | -0,89 -0,85 -4.71% | -0,76 -0,87 12.64% | -0,78 | -0,69 |
| Announcement Date | 27/03/23 | 29/03/24 | 25/03/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,59 -4,68 -19.47% | -4,70 -5,73 17.99% | -7,39 -4,86 -52.07% | -4,99 -7,63 34.65% | -6,72 -4,96 -35.38% | -7,66 -6,38 -20.2% | -7,86 | -8,07 | -8,28 | -9,41 | -10,8 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,32 -4,68 -13.75% | -4,40 -5,46 19.55% | -7,14 -4,60 -55.08% | -4,80 -7,38 34.95% | -6,61 -4,74 -39.47% | -7,58 -6,16 -23.12% | -7,39 | -7,67 | -7,98 | -9,21 | -10,7 | |
|
Net income Million USD | Released Forecast Spread | -5,26 -4,69 -12.25% | -4,39 -5,46 19.6% | -7,15 -4,60 -55.32% | -4,81 -7,38 34.8% | -6,62 -4,74 -39.66% | -7,59 -6,16 -23.24% | -7,39 | -7,67 | -7,98 | -9,21 | -10,7 | |
|
EPS USD | Released Forecast Spread | -0,22 -0,23 4.35% | -0,15 -0,21 28.57% | -0,24 -0,16 -50% | -0,15 -0,25 40% | -0,15 -0,23 34.78% | -0,22 -0,16 -37.5% | -0,24 -0,19 -26.32% | -0,16 | -0,14 | -0,15 | -0,17 | -0,19 |
| Announcement Date | 09/05/24 | 12/08/24 | 12/11/24 | 25/03/25 | 08/05/25 | 08/08/25 | 07/11/25 | - | - | - | - | - |
| 2026-01-14 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-04 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-05 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-02-09 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-09 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-10 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-10 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-11 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-11 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-15 | Q4 2025 Sales and Revenue Release | Add to your calendar Google Apple ICS format |
Past sector events for Immix Biopharma, Inc.
| Today | Q3 2025 Earnings Release | |
| 2025-12-08 | November 2025 Sales and Revenue Release | |
| 2025-12-05 | November 2025 Sales and Revenue Release | |
| 2025-12-05 | November 2025 Sales and Revenue Release | |
| 2025-12-04 | Q3 2025 Earnings Release | |
| 2025-12-03 | Q2 2026 Earnings Release (Projected) | |
| 2025-11-25 | Q4 2025 Earnings Release | |
| 2025-11-21 | Q3 2025 Sales and Revenue Release | |
| 2025-11-17 | Q3 2025 Earnings Release | |
| 2025-11-14 | Q3 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMMX Stock
- Calendar Immix Biopharma, Inc.
Select your edition
All financial news and data tailored to specific country editions
















